Zimmer Biomet wins Trilogy hip implant suit
A federal jury in Texas last week cleared Zimmer Biomet (NYSE:ZBH) in a product liability lawsuit brought over its recalled Trilogy hip implant.
Plaintiff Martha Hardy sued Zimmer Biomet in March 2016, 4 years after a total right hip arthroplasty using the company’s Trilogy acetabular shell and Trilogy acetabular spike but before the devices were pulled from the market in June 2012 ( a full recall went into effect in September of that year, after the FDA sent Zimmer Biomet a warning letter).
“Unbeknownst to Plaintiff or her surgeon, the Plaintiff was being surgically implanted with “adulterated” a...
Source: Mass Device - May 8, 2017 Category: Medical Equipment Authors: Brad Perriello Tags: Legal News Product Liability Zimmer Biomet Source Type: news
Judge Halves $1 Billion Award In Johnson & Johnson Hip Implant Case
(Reuters) - A U.S. judge almost halved the award in a December jury verdict that ordered Johnson & Johnson and its DePuy Orthopaedics unit to pay more than $1 billion to plaintiffs in six lawsuits who said they were injured by DePuy’s Pinnacle hip implants.
U.S. District Judge Ed Kinkeade in Dallas cited “constitutional considerations” that limit how much plaintiffs may recover in punitive damages but upheld the jury’s findings that the implants were defectively designed and that the companies failed to warn consumers about the risks.
Around $500 million of punitive damages would be cut from the...
Source: Healthy Living - The Huffington Post - January 4, 2017 Category: Consumer Health News Source Type: news
Johnson & Johnson ordered to pay $1 billion settlement
A federal jury in Dallas has ordered Johnson& Johnson and its subsidiary DePuy Orthopaedics to pay more than $1 billion to a group of plaintiffs over artificial hip replacements. (Source: CNN.com - Health)
Source: CNN.com - Health - December 2, 2016 Category: Consumer Health News Source Type: news
Saving Bad Hips with 3D Technology
CHICAGO. (Ivanhoe Newswire) -- More than 2.5 million Americans are living with an artificial hip. For those with a failed hip replacement, many are either too afraid to have a revision or don’t know what can be done and instead live with the pain and disability. But there is hope. Now, 3D technology is helping surgeons plan and perform the surgery better than ever before. (Source: Medical Headlines From Ivanhoe.com)
Source: Medical Headlines From Ivanhoe.com - April 26, 2016 Category: Consumer Health News Source Type: news
Health Highlights: March 18, 2016
Chicken of the Sea Tuna Recalled Two New Ebola Cases Confirmed in Guinea: WHO J&J Told to Pay $502 Million in Artificial Hip Lawsuit Decision (Source: U.S. News - Health)
Source: U.S. News - Health - March 18, 2016 Category: Consumer Health News Source Type: news
Health Highlights: March 17, 2016
J&J Told to Pay $502 Million in Artificial Hip Lawsuit Decision Death Toll in Wisc. Blood Infection Outbreak Rises to 17 E. Coli Outbreak Traced to Pizza Chain Desserts Bumble Bee Tuna Recalled (Source: U.S. News - Health)
Source: U.S. News - Health - March 17, 2016 Category: Consumer Health News Source Type: news
New surgical technique improves biological hip joint replacement
(University of Missouri-Columbia) Traditional hip replacement procedures reduce pain and restore mobility. However, for younger, more active patients, an artificial hip has a limited lifetime and usually requires restricted activity. Now, researchers at the University of Missouri School of Medicine have tested a new biological technique that may provide better and longer-lasting joint function. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 22, 2016 Category: Global & Universal Source Type: news
Strong dollar pushes Smith & Nephew to cut margins forecast
Smith & Nephew (NYSE:SNN) today said it expects its margins to shrink by 1.2% this year due to the strong dollar despite a forecast for top-line growth.
Europe’s largest maker of artificial hips and knees posted 4th-quarter revenues of $1.26 billion, up 0.6% compared with Q4 2014. Smith & Nephew no longer reports quarterly profit or earnings numbers.
Full-year profits were down -18.2% to $410 million, or 45.9¢ per share, on sales growth of 0.4% to $4.63 billion. Adjusted EPS were 85.1¢, well below the $1.61 consensus forecast on Wall Street, where analysts were looking for sales of $4.61 billion.
“Th...
Source: Mass Device - February 4, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: MassDevice Earnings Roundup Wall Street Beat Smith & Nephew Source Type: news
Surgical funder ordered to turn over information on DePuy hip surgeries
(Reuters) — A federal judge yesterday ordered a surgical funding company to turn over information about payments it made to healthcare providers for surgeries performed on plaintiffs suing over artificial hips made by a unit of Johnson & Johnson (NYSE:JNJ).
DePuy Orthopaedics in August sought to compel Texas-based MedStar Funding to hand over the information, saying it was concerned that Medstar was trying to squeeze excessive profits from liens it had placed against personal-injury settlements for 11 hip plaintiffs.
Yesterday U.S. District Judge David Katz in Toledo granted the motion and directed Medstar to compl...
Source: Mass Device - October 14, 2015 Category: Medical Equipment Authors: MassDevice Tags: Legal News Orthopedics DePuy Orthopedics Johnson & Johnson Medstar Source Type: news
Surgical funder ordered to turn over information on hip surgeries
NEW YORK (Reuters) - A federal judge has ordered a surgical funding company to turn over information about payments it made to healthcare providers for surgeries performed on plaintiffs suing over artificial hips made by a unit of Johnson & Johnson. (Source: Reuters: Health)
Source: Reuters: Health - October 14, 2015 Category: Consumer Health News Tags: healthNews Source Type: news
Hip Implant Maker Claims Surgical Funder Inflated Patients' BillsHip Implant Maker Claims Surgical Funder Inflated Patients' Bills
A unit of Johnson & Johnson that makes artificial hips has accused a surgical funding company of seeking excessive profits from financing surgery for patients suing over the devices. Reuters Health Information (Source: Medscape Orthopaedics Headlines)
Source: Medscape Orthopaedics Headlines - September 29, 2015 Category: Orthopaedics Tags: Family Medicine/Primary Care News Source Type: news
Hip implant maker claims surgical funder inflated patients’ bills
(Reuters) - A unit of Johnson & Johnson that makes artificial hips has accused a surgical funding company of seeking excessive profits from financing surgery for patients suing over the devices. (Source: Reuters: Health)
Source: Reuters: Health - September 28, 2015 Category: Consumer Health News Tags: healthNews Source Type: news
Stryker Agrees To Settle Hip Implant Suits For $1.43B
After months of mediation with plaintiffs, Stryker Corporation recently agreed to settle more than 4,000 suits over defective all-metal artificial hip implants for at least $1.43 billion. (Source: Medical Design Online News)
Source: Medical Design Online News - November 5, 2014 Category: Medical Equipment Source Type: news
Review: cobalt toxicity and artificial metal hips
4.5 out of 5 stars
Systemic toxicity related to metal hip prostheses. Bradberry SM et al. Clin Toxicol 2014;52:837-847.
Abstract
As TPR has reported before, cobalt poisoning can cause hypothyroidism, cardiomyopathy, and neurotoxicity. Neurological manifestations include:
optic nerve damage and retinopathy with reduced visual acuity
bilateral nerve deafness and tinnitus
polyneuropathy (sensory and motor)
cognitive impairment and memory loss
A number of papers and case reports have described clinical cobalt toxicity related to metal-on-metal hip prostheses or revision of a failed ceramic prosthesis with metal parts. Al...
Source: The Poison Review - September 25, 2014 Category: Toxicology Authors: Leon Tags: Medical cardiomyopathy cobalt toxicity hip replacement hypothyroidism neurotoxicity prosthesis Source Type: news
Smith & Nephew Slashes Costs Of Orthopedic Offerings
European orthopedic device-maker Smith & Nephew will offer U.S. hospitals discounted prices on its artificial hips and joints as part of a new “no frills” strategy designed to build up its position in an increasingly competitive market. (Source: Medical Design Online News)
Source: Medical Design Online News - August 5, 2014 Category: Medical Equipment Source Type: news
